bw 306u has been researched along with Nicotine Addiction in 1 studies
hydroxybupropion: active metabolite of bupropion; structure in first source
Excerpt | Relevance | Reference |
---|---|---|
"Preclinical studies with bupropion in rodent models of nicotine dependence have generated equivocal findings with regard to translating the clinical efficacy of the antidepressant as a smoking cessation agent." | 3.81 | Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats. ( Blough, B; Carroll, FI; Damaj, MI; Malcolm, E; Shoaib, M, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Malcolm, E | 1 |
Carroll, FI | 1 |
Blough, B | 1 |
Damaj, MI | 1 |
Shoaib, M | 1 |
1 other study available for bw 306u and Nicotine Addiction
Article | Year |
---|---|
Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Bupropion; Male; Nicotine; Rats; Receptors, Nico | 2015 |